ArticleClinical oral investigations2026
Lymph node metastasis pattern in recurrent and ipsilateral second primary oral squamous cell carcinoma.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo examine the patterns of lymph node metastasis and associated risk factors in patients with recurrent tumors or ipsilateral second primary tumors (SPT), with the goal of providing insights for clinical diagnosis and management.
methodsA retrospective analysis was conducted on patients who underwent radical surgery for oral squamous cell carcinoma (OSCC) and experienced tumor recurrence or ipsilateral SPT between January 2017 and March 2023. Comprehensive clinical and pathological data were collected at both the time of initial treatment and recurrent or ipsilateral SPT.
resultsMost common primary OSCC sites were the tongue and buccal mucosa, while recurrent and ipsilateral SPT primarily occurred in the buccal mucosa. The lymph node metastasis rate for primary OSCC was 22.9%, increasing to 42.2% in recurrent and ipsilateral SPT (p < 0.001). Primary OSCC tended to metastasize to levels I-III, while recurrent and ipsilateral SPT more commonly metastasized to ipsilateral level V and contralateral level I. Multivariate logistic regression showed moderately and poorly tumor differentiation and T2 stage were significant risk factors for lymph node metastasis in primary OSCC. In recurrent and ipsilateral SPT, poorly differentiated tumors and T2 stage were similarly associated with increased lymph node metastasis. Both lymph node and distant metastases were significant prognostic risk factors in recurrent or ipsilateral SPT.
conclusionRecurrent and ipsilateral SPT exhibit a higher likelihood of lymph node metastasis compared to primary OSCC, particularly to ipsilateral level V and contralateral level I lymph nodes. This pattern of metastasis is strongly associated with a poorer prognosis.
Indexed as
Identifiers
41538100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.